| Identification | Back Directory | [Name]
1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea | [CAS]
2731294-23-6 | [Synonyms]
Ofirnoflastum (Ofirnoflast)
1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea
Urea, N-[4-(4-amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl]-N′-[5-[1-(trifluoromethyl)cyclopropyl]-3-isoxazolyl]- | [Molecular Formula]
C23H19F4N7O2 | [MOL File]
2731294-23-6.mol | [Molecular Weight]
501.44 |
| Chemical Properties | Back Directory | [Boiling point ]
614.176±55.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.738±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [form ]
Solid | [pka]
12.141±0.70(predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Ofirnoflastum (Ofirnoflast) is a serine/ threonine-protein kinase Nek7 inhibitor, with anti inflammatory effect[1]. | [References]
[1] Ofirnoflastum (Ofirnoflast). WHO Drug Information, Vol. 37, No. 4, 2023. |
|
|